Taru S. Dutt

494 total citations
22 papers, 228 citations indexed

About

Taru S. Dutt is a scholar working on Infectious Diseases, Molecular Biology and Epidemiology. According to data from OpenAlex, Taru S. Dutt has authored 22 papers receiving a total of 228 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Infectious Diseases, 7 papers in Molecular Biology and 7 papers in Epidemiology. Recurrent topics in Taru S. Dutt's work include Tuberculosis Research and Epidemiology (8 papers), Mycobacterium research and diagnosis (7 papers) and Long-Term Effects of COVID-19 (5 papers). Taru S. Dutt is often cited by papers focused on Tuberculosis Research and Epidemiology (8 papers), Mycobacterium research and diagnosis (7 papers) and Long-Term Effects of COVID-19 (5 papers). Taru S. Dutt collaborates with scholars based in United States, Italy and United Kingdom. Taru S. Dutt's co-authors include Marcela Henao‐Tamayo, Andrés Obregón‐Henao, Ger T. Rijkers, Frans J. van Overveld, Rajiv K. Saxena, Amy Fox, Julie Dunn, Tracy L. Webb, Stephanie M. LaVergne and G. Brooke Anderson and has published in prestigious journals such as The Journal of Immunology, Scientific Reports and Frontiers in Immunology.

In The Last Decade

Taru S. Dutt

21 papers receiving 224 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Taru S. Dutt United States 10 130 58 46 43 42 22 228
Nicholas Kim‐Wah Yeo Singapore 6 167 1.3× 54 0.9× 22 0.5× 66 1.5× 70 1.7× 8 320
Geqing Xia China 7 91 0.7× 42 0.7× 24 0.5× 31 0.7× 33 0.8× 13 237
Inès Bendib France 6 130 1.0× 45 0.8× 51 1.1× 77 1.8× 92 2.2× 10 266
Michelle M. Thomsen Denmark 8 118 0.9× 49 0.8× 62 1.3× 78 1.8× 65 1.5× 12 244
Nicholas C. Morano United States 5 189 1.5× 42 0.7× 38 0.8× 34 0.8× 39 0.9× 12 264
Sivagurunathan Sutharsan Germany 12 124 1.0× 55 0.9× 51 1.1× 49 1.1× 21 0.5× 62 501
Natalia G. Herrera United States 4 175 1.3× 32 0.6× 25 0.5× 33 0.8× 39 0.9× 6 249
Sharlene Sy United States 3 245 1.9× 29 0.5× 41 0.9× 44 1.0× 60 1.4× 5 305
Qinghua Qiao China 6 228 1.8× 31 0.5× 20 0.4× 28 0.7× 87 2.1× 10 267
Lena Hansen Norway 6 286 2.2× 87 1.5× 53 1.2× 109 2.5× 52 1.2× 11 464

Countries citing papers authored by Taru S. Dutt

Since Specialization
Citations

This map shows the geographic impact of Taru S. Dutt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Taru S. Dutt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Taru S. Dutt more than expected).

Fields of papers citing papers by Taru S. Dutt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Taru S. Dutt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Taru S. Dutt. The network helps show where Taru S. Dutt may publish in the future.

Co-authorship network of co-authors of Taru S. Dutt

This figure shows the co-authorship network connecting the top 25 collaborators of Taru S. Dutt. A scholar is included among the top collaborators of Taru S. Dutt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Taru S. Dutt. Taru S. Dutt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tobi, Martin, Diptaraj Chaudhari, Noreen F. Rossi, et al.. (2025). Immune Signatures in Post-Acute Sequelae of COVID-19 (PASC) and Myalgia/Chronic Fatigue Syndrome (ME/CFS): Insights from the Fecal Microbiome and Serum Cytokine Profiles. Biomolecules. 15(7). 928–928. 1 indexed citations
2.
Dutt, Taru S., Silvain Pinaud, B Graham, et al.. (2025). A single-cell atlas of the Culex tarsalis midgut during West Nile virus infection. PLoS Pathogens. 21(1). e1012855–e1012855. 3 indexed citations
3.
4.
Dutt, Taru S., Amy L. MacNeill, H. Lam, et al.. (2024). A modified BPaL regimen for tuberculosis treatment replaces linezolid with inhaled spectinamides. eLife. 13. 1 indexed citations
5.
LaVergne, Stephanie M., Taru S. Dutt, Kim McFann, et al.. (2024). Persistent CD8+ T cell proliferation and activation in COVID-19 adult survivors with post-acute sequelae: a longitudinal, observational cohort study of persistent symptoms and T cell markers. Frontiers in Immunology. 14. 1303971–1303971. 4 indexed citations
6.
Dutt, Taru S., Amy L. MacNeill, H. Lam, et al.. (2024). A modified BPaL regimen for tuberculosis treatment replaces linezolid with inhaled spectinamides. eLife. 13. 5 indexed citations
7.
Dutt, Taru S., Amy Fox, Elizabeth Creissen, et al.. (2022). Mucosal exposure to non-tuberculous mycobacteria elicits B cell-mediated immunity against pulmonary tuberculosis. Cell Reports. 41(11). 111783–111783. 12 indexed citations
8.
Dutt, Taru S., Kim McFann, Tracy L. Webb, et al.. (2022). 78. Longitudinal Analysis of T cells in COVID-19 Survivors with Post-Acute Sequelae of COVID-19 Reveals Associations between Individual Symptoms and Inflammatory Indexes. Open Forum Infectious Diseases. 9(Supplement_2). 1 indexed citations
9.
Dutt, Taru S., Amy Fox, Elizabeth Creissen, et al.. (2022). Mucosal Exposure to Non-Tuberculous Mycobacteria Elicits B-Cell-Mediated Protection Against Pulmonary Tuberculosis. SSRN Electronic Journal. 1 indexed citations
10.
Dooley, Gregory, Stephanie M. LaVergne, Emily N. Gallichotte, et al.. (2022). Relationships between plasma fatty acids in adults with mild, moderate, or severe COVID-19 and the development of post-acute sequelae. Frontiers in Nutrition. 9. 960409–960409. 9 indexed citations
11.
12.
Ragan, Izabela, Taru S. Dutt, Andrés Obregón‐Henao, et al.. (2021). A Whole Virion Vaccine for COVID-19 Produced via a Novel Inactivation Method and Preliminary Demonstration of Efficacy in an Animal Challenge Model. Vaccines. 9(4). 340–340. 15 indexed citations
13.
LaVergne, Stephanie M., Tracy L. Webb, Taru S. Dutt, et al.. (2021). A longitudinal SARS-CoV-2 biorepository for COVID-19 survivors with and without post-acute sequelae. BMC Infectious Diseases. 21(1). 677–677. 36 indexed citations
14.
Dutt, Taru S., et al.. (2021). Effect of non-tuberculous mycobacteria on the protective efficacy of BCG vaccine via modulation of mucosal immunity. The Journal of Immunology. 206(1_Supplement). 65.11–65.11. 1 indexed citations
15.
Rijkers, Ger T., et al.. (2021). Antigen Presentation of mRNA-Based and Virus-Vectored SARS-CoV-2 Vaccines. Vaccines. 9(8). 848–848. 70 indexed citations
16.
Fox, Amy, Taru S. Dutt, Mauricio Rojas, et al.. (2020). Cyto-Feature Engineering: A Pipeline for Flow Cytometry Analysis to Uncover Immune Populations and Associations with Disease. Scientific Reports. 10(1). 7651–7651. 9 indexed citations
17.
Tiwari, Sangeeta, Taru S. Dutt, Bing Chen, et al.. (2020). BCG-Prime and boost with Esx-5 secretion system deletion mutant leads to better protection against clinical strains of Mycobacterium tuberculosis. Vaccine. 38(45). 7156–7165. 19 indexed citations
18.
19.
Dutt, Taru S. & Rajiv K. Saxena. (2019). Enhanced antibody response to ovalbumin coupled to poly-dispersed acid functionalized single walled carbon nanotubes. Immunology Letters. 217. 77–83. 10 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nicholas Kim‐Wah Yeo Breakdown of academic impact, for papers by Geqing Xia Breakdown of academic impact, for papers by Inès Bendib Breakdown of academic impact, for papers by Michelle M. Thomsen Breakdown of academic impact, for papers by Nicholas C. Morano Breakdown of academic impact, for papers by Sivagurunathan Sutharsan Breakdown of academic impact, for papers by Natalia G. Herrera Breakdown of academic impact, for papers by Sharlene Sy Breakdown of academic impact, for papers by Qinghua Qiao Breakdown of academic impact, for papers by Lena Hansen
Rankless by CCL
2026